Your browser doesn't support javascript.
loading
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Nokihara, H; Lu, S; Mok, T S K; Nakagawa, K; Yamamoto, N; Shi, Y K; Zhang, L; Soo, R A; Yang, J C; Sugawara, S; Nishio, M; Takahashi, T; Goto, K; Chang, J; Maemondo, M; Ichinose, Y; Cheng, Y; Lim, W T; Morita, S; Tamura, T.
Afiliación
  • Nokihara H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai.
  • Mok TSK; Department of Clinical Oncology, State Key Laboratory in Oncology in South China, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: tony@clo.cuhk.edu.hk.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka.
  • Yamamoto N; Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
  • Shi YK; Department of Medical Oncology, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
  • Zhang L; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Soo RA; Department of Hematology-Oncology, National University Hospital, Cancer Science Institute of Singapore, Singapore.
  • Yang JC; Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi.
  • Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo.
  • Takahashi T; Department of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Chang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Maemondo M; Department of Thoracic Oncology, Miyagi Cancer Center, Miyagi.
  • Ichinose Y; Department of Cancer Information Research, National Kyushu Cancer Center, Clinical Research Institute, Fukuoka, Japan.
  • Cheng Y; Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China.
  • Lim WT; Department of Medical Oncology, National Cancer Center Singapore, Singapore.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto.
  • Tamura T; Thoracic Center, St Luke's International Hospital, Tokyo, Japan.
Ann Oncol ; 28(11): 2698-2706, 2017 Nov 01.
Article en En | MEDLINE | ID: mdl-29045553

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido